Structural optimization of imidazothiazole derivatives affords a new promising series as B-Raf V600E inhibitors; synthesis, in vitro assay and in silico screening

Authors
Ammar, Usama M.Abdel-Maksoud, Mohammed S.Ali, Eslam M. H.Mersal, Karim, IYoo, Kyung HoOh, Chang-Hyun
Issue Date
2020-07
Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
Citation
BIOORGANIC CHEMISTRY, v.100
Keywords
BIOLOGICAL EVALUATION; MALIGNANT-MELANOMA; BRAF; MUTATIONS; ENCORAFENIB; VEMURAFENIB; GROWTH; AGENTS; KINASE; BIOLOGICAL EVALUATION; MALIGNANT-MELANOMA; BRAF; MUTATIONS; ENCORAFENIB; VEMURAFENIB; GROWTH; AGENTS; KINASE; anti cancer; B-Raf V600E; Imidazo[2,1-b]thiazole; In silico screening
ISSN
0045-2068
URI
https://pubs.kist.re.kr/handle/201004/118430
DOI
10.1016/j.bioorg.2020.103967
Appears in Collections:
KIST Article > 2020
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE